INHIBITION OF ADRENOCORTICAL RESPONSIVENESS DURING PROGESTIN THERAPY.
D000309:Adrenal Insufficiency; D000324:Adrenocorticotropic Hormone; D003270:Contraceptive Agents; D003276:Contraceptives, Oral; D004997:Ethinyl Estradiol; D006801:Humans; D007659:Ketones; D008656:Mestranol; D008797:Metyrapone; D000451:Mineralocorticoid Receptor Antagonists; D009640:Norethindrone; D009641:Norethynodrel; D010600:Pharmacology; D010912:Pituitary-Adrenal Function Tests; D011372:Progestins
D003270:Contraceptive Agents; D003276:Contraceptives, Oral; D007659:Ketones; D000451:Mineralocorticoid Receptor Antagonists; D011372:Progestins; D004997:Ethinyl Estradiol; D009641:Norethynodrel; D000324:Adrenocorticotropic Hormone; D008656:Mestranol; D009640:Norethindrone; D008797:Metyrapone
ADRENAL GLAND HYPOFUNCTION; ALDOSTERONE ANTAGONISTS; CONTRACEPTIVES, ORAL; CORTICOTROPIN; ETHINYL ESTRADIOL; KETONES; MESTRANOL; METYRAPONE; NORETHINDRONE; NORETHYNODREL; PHARMACOLOGY; PITUITARY-ADRENAL FUNCTION TESTS